| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/06/2022 | 1.89% | HC Wainwright & Co. | $161 → $76 | Downgrades | Buy → Neutral |
| 06/03/2022 | 1.89% | Wedbush | $61 → $76 | Downgrades | Outperform → Neutral |
| 05/24/2022 | 55.52% | Goldman Sachs | $143 → $116 | Maintains | Buy |
| 05/20/2022 | -22.24% | B of A Securities | → $58 | Initiates Coverage On | → Buy |
| 05/11/2022 | 35.41% | SVB Leerink | $107 → $101 | Maintains | Outperform |
| 03/22/2022 | 115.85% | HC Wainwright & Co. | $162 → $161 | Maintains | Buy |
| 03/01/2022 | -39.67% | Stifel | $50 → $45 | Maintains | Hold |
| 02/10/2022 | 13.96% | Wells Fargo | $120 → $85 | Maintains | Overweight |
| 01/21/2022 | 40.77% | Oppenheimer | $115 → $105 | Maintains | Outperform |
| 12/07/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/10/2021 | 54.18% | Oppenheimer | $150 → $115 | Maintains | Outperform |
| 10/12/2021 | 117.19% | HC Wainwright & Co. | $178 → $162 | Maintains | Buy |
| 10/11/2021 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 09/30/2021 | 0.55% | Stifel | → $75 | Initiates Coverage On | → Hold |
| 04/06/2021 | 149.36% | HC Wainwright & Co. | $190 → $186 | Maintains | Buy |
| 02/02/2021 | 94.4% | Canaccord Genuity | $122 → $145 | Maintains | Buy |
| 01/19/2021 | 154.73% | HC Wainwright & Co. | $130 → $190 | Maintains | Buy |
| 12/14/2020 | 70.26% | SVB Leerink | $116 → $127 | Maintains | Outperform |
| 12/08/2020 | 67.58% | JMP Securities | → $125 | Initiates Coverage On | → Market Outperform |
| 10/27/2020 | 63.56% | Canaccord Genuity | $85 → $122 | Maintains | Buy |
| 10/26/2020 | 74.29% | HC Wainwright & Co. | $100 → $130 | Maintains | Buy |
| 10/26/2020 | 55.52% | SVB Leerink | $77 → $116 | Maintains | Outperform |
| 09/21/2020 | 34.07% | HC Wainwright & Co. | $88 → $100 | Maintains | Buy |
| 08/21/2020 | 13.96% | Canaccord Genuity | $80 → $85 | Maintains | Buy |
| 07/10/2020 | 20.66% | Oppenheimer | → $90 | Initiates Coverage On | → Outperform |
| 05/26/2020 | 17.98% | HC Wainwright & Co. | $72 → $88 | Maintains | Buy |
| 05/13/2020 | 1.89% | Wells Fargo | $62 → $76 | Maintains | Overweight |
| 05/13/2020 | -10.18% | SVB Leerink | $60 → $67 | Maintains | Outperform |
| 03/17/2020 | -3.47% | HC Wainwright & Co. | $70 → $72 | Maintains | Buy |
| 11/14/2019 | -12.86% | Roth Capital | → $65 | Initiates Coverage On | → Buy |
| 09/25/2019 | -6.15% | HC Wainwright & Co. | → $70 | Initiates Coverage On | → Buy |
| 09/10/2019 | -15.54% | Wedbush | → $63 | Initiates Coverage On | → Outperform |
| 09/05/2019 | -24.92% | Canaccord Genuity | $53 → $56 | Maintains | Buy |
| 09/04/2019 | -16.88% | Wells Fargo | $53 → $62 | Maintains | Outperform |
| 07/24/2019 | -22.24% | Guggenheim | → $58 | Initiates Coverage On | → Buy |
| 05/13/2019 | -43.69% | SVB Leerink | → $42 | Initiates Coverage On | → Outperform |
| 05/13/2019 | -28.94% | Wells Fargo | → $53 | Initiates Coverage On | → Outperform |
| 05/13/2019 | -32.97% | Goldman Sachs | → $50 | Initiates Coverage On | → Buy |
| 05/13/2019 | -35.65% | Canaccord Genuity | → $48 | Initiates Coverage On | → Buy |
Turning Point Questions & Answers
The latest price target for Turning Point (NASDAQ: TPTX) was reported by Wedbush on June 3, 2022. The analyst firm set a price target for $76.00 expecting TPTX to rise to within 12 months (a possible 1.89% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Turning Point (NASDAQ: TPTX) was provided by Wedbush, and Turning Point downgraded their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Turning Point, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Turning Point was filed on June 3, 2022 so you should expect the next rating to be made available sometime around June 3, 2023.
While ratings are subjective and will change, the latest Turning Point (TPTX) rating was a downgraded with a price target of $61.00 to $76.00. The current price Turning Point (TPTX) is trading at is $74.59, which is within the analyst's predicted range.